Protagonist Therapeutics, Inc. (PTGX)
98.87
-2.81
(-2.76%)
USD |
NASDAQ |
Mar 20, 16:00
98.91
+0.04
(+0.04%)
Pre-Market: 20:00
Protagonist Therapeutics EPS Diluted (Quarterly) : -0.6932 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Johnson & Johnson | 2.098 |
| AbbVie, Inc. | 1.018 |
| Insmed, Inc. | -1.538 |
| Madrigal Pharmaceuticals, Inc. | -2.566 |
| PTC Therapeutics, Inc. | -1.673 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -44.38M |
| Revenue (Quarterly) | 7.437M |
| Total Expenses (Quarterly) | 51.82M |
| Enterprise Value | 5.752B |
| Gross Profit Margin (Quarterly) | 94.94% |
| Profit Margin (Quarterly) | -596.8% |
| Earnings Yield | -2.07% |
| Normalized Earnings Yield | -2.066 |